The change in the differentiation ability of LSCs after exposure to AML cell-derived EVs was also assessed, which depicted that the differentiation ability of LSCs was negatively-correlated with the concentration of EVs, evidenced by decreased CD19, CD3 and CD235a positive cells and increased CD33 positive cells (Figure 2F). The gene discussed is CD33; the disease is acute myeloid leukemia.